隐匿性乙型肝炎感染与肝细胞癌:流行病学、病毒学、肝癌发生机制及临床意义
隐匿性乙型肝炎感染(OBI)指血清HBsAg阴性但肝内存在复制 Competent 的HBV DNA。OBI患病率因地域、检测方法、宿主免疫、合并病毒感染及疫苗接种状况而异。OBI与慢性HCV感染、隐源性或已知肝病及HBsAg血清清除后患者的HCC发生相关,前瞻性研究和Meta分析报告合并OBI的HCV患者HCC发生率更高、肿瘤组织学分级更晚、诊断年龄更早。
要点
- OBI定义为血清HBsAg阴性但肝内存在复制 Competent 的HBV DNA,可伴或不伴血HBV DNA。
- OBI患病率因地域、检测方法、宿主免疫、合并病毒感染和疫苗接种状况而异。
- OBI与HCV感染、隐源性或已知肝病及HBsAg血清清除后患者的HCC发生相关。
核心结论
- OBI与慢性HCV感染、隐源性或已知肝病及HBsAg血清清除后患者的HCC发生相关,合并OBI的HCV患者HCC发生率更高、肿瘤组织学分级更晚、诊断年龄更早。
- OBI相关HCC的致病机制尚不完全明确,涉及HBV DNA整合、促癌蛋白产生及持续低度坏死性炎症。
研究设计与样本
- 综述,总结OBI与HCC的流行病学、病毒学、肝癌发生机制及临床意义。
主要发现
- OBI肝内存在低复制状态的游离共价闭合环状DNA(cccDNA),病毒基因表达受表观遗传调控,模式与慢性HBV感染者不同。
- OBI患病率因地理区域、检测方法特性、宿主免疫应答、合并其他病毒感染及疫苗接种状况等因素而在不同患者群体中差异巨大。
- OBI与免疫抑制时病毒再激活风险、HBV传播风险相关,并涉及慢性HCV感染、隐源性或已知肝病及HBsAg血清清除后患者的HCC发生。
- 越来越多的前瞻性研究和Meta分析报告,合并OBI的HCV患者较无OBI患者HCC发生率更高、肿瘤组织学分级更晚、HCC诊断年龄更早。
- OBI相关HCC的推测机制包括HBV DNA整合影响肝细胞周期、产生促癌蛋白(HBx蛋白和突变表面蛋白)及持续低度坏死性炎症促进纤维化和肝硬化。
局限性
- 原文指出,OBI相关HCC的确切机制及其驱动肿瘤发生的顺序仍存在不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Occult hepatitis B infection (OBI) refers to a condition where replication-competent HBV DNA is present in the liver, with or without HBV DNA in the blood, in individuals with serum HBsAg negativity assessed by currently available assays. The episomal covalently closed circular DNA (cccDNA) in OBI is in a low replicative state. Viral gene expression is mediated by epigenetic control of HBV transcription, including the HBV CpG island methylation pathway and post-translational modification of cccDNA-bound histone, with a different pattern from patients with chronic HBV infection. The prevalence of OBI varies tremendously across patient populations owing to numerous factors, such as geographic location, assay characteristics, host immune response, coinfection with other viruses, and vaccination status. Apart from the risk of viral reactivation upon immunosuppression and the risk of transmission of HBV, OBI has been implicated in hepatocellular carcinoma (HCC) development in patients with chronic HCV infection, those with cryptogenic or known liver disease, and in patients with HBsAg seroclearance after chronic HBV infection. An increasing number of prospective studies and meta-analyses have reported a higher incidence of HCC in patients with HCV and OBI, as well as more advanced tumour histological grades and earlier age of HCC diagnosis, compared with patients without OBI. The proposed pathogenetic mechanisms of OBI-related HCC include the influence of HBV DNA integration on the hepatocyte cell cycle, the production of pro-oncogenic proteins (HBx protein and mutated surface proteins), and persistent low-grade necroinflammation (contributing to the development of fibrosis and cirrhosis). There remain uncertainties about exactly how, and in what order, these mechanisms drive the development of tumours in patients with OBI.
引用
- Mak LY, Wong DK, Pollicino T, et al. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020. PMID: 32504662. doi:10.1016/j.jhep.2020.05.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。